WFG Advisors’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

WFG Advisors’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-400	Closed	-$5K	–	1761
2016 Q4	$5K	Sell	400 -250	-38%	-$3.01K	﹤0.01%	1290
2016 Q3	$9K	Buy	+650	New	+$6.53K	﹤0.01%	1173
2016 Q2	–	Sell	-250	Closed	-$2K	–	1774
2016 Q1	$2K	Hold	250	–	–	﹤0.01%	1374
2015 Q4	$2K	Hold	250	–	–	﹤0.01%	1412
2015 Q3	$1K	Hold	250	–	–	﹤0.01%	1570
2015 Q2	$2K	Buy	+250	New	+$2.21K	﹤0.01%	1526

Other funds holding ARIA

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

WFG Advisors's ARIA Position: Q1 2017 in Review

WFG Advisors sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 400 shares — an estimated $5K sold.

WFG Advisors first reported a position in ARIA in Q2 2015 and held it in 6 quarters. The position peaked at $9K in Q3 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

WFG Advisors reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
WFG Advisors sold 400 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $5K.
WFG Advisors first reported a position in Ariad Pharmaceuticals Inc in Q2 2015 and held it in 6 quarters.
WFG Advisors's Ariad Pharmaceuticals Inc position peaked at $9K in Q3 2016.
1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on WFG Advisors's 13F filing for Q1 2017, filed 10 May 2017.